Dr. Schoettler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Summary
- Dr. Peter Schoettler is a pediatric hematologist/oncologist in Rochester, MN and is affiliated with Mayo Clinic. He received his medical degree from University of Minnesota Medical School. He completed his Pediatric Residency training at University of California-Irvine/Children's Hospital of Orange County. He completed his Pediatric Hematology-Oncology Fellowship at University of Texas-Southwestern Medical Center. He has been in practice 2+ years. He specializes in pediatric sarcoma oncology and pediatric solid tumor oncology.
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 2018 - 2021
- Children's Hospital of Orange CountyResidency, Pediatrics, 2015 - 2018
- University of Minnesota Medical SchoolClass of 2015
Certifications & Licensure
- MN State Medical License 2023 - 2025
- MI State Medical License 2021 - 2024
- CA State Medical License 2017 - 2019
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 22 citationsPediatric superior vena cava syndrome: An evidence-based systematic review of the literature.Fadi Nossair, Peter Schoettler, Joanne P. Starr, Anthony K.C. Chan, Ivan I. Kirov
Pediatric Blood & Cancer. 2018-09-01 - 136 citationsType I pleuropulmonary blastoma: pathology and biology study of 51 cases from the international pleuropulmonary blastoma registry.D. Hill, Jason A. Jarzembowski, John R. Priest, Gretchen M. Williams, Peter Schoettler
The American Journal of Surgical Pathology. 2008-02-01 - 51 citationsTemporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in pleuropulmonary blastoma / DICER1 syndrome: a unique variant of ...Mark Brenneman, Amanda Field, Jiandong Yang, Gretchen M. Williams, Leslie Doros
F1000research. 2018-01-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: